Latimer, N.R. orcid.org/0000-0001-5304-5585, Towse, A. and Henshall, C. (2021) Not cost-effective at zero price : valuing and paying for combination therapies in cancer. Expert Review of Pharmacoeconomics & Outcomes Research, 21 (3). pp. 331-333. ISSN 1473-7167
Metadata
Item Type: | Article |
---|---|
Authors/Creators: |
|
Copyright, Publisher and Additional Information: | © 2021 Informa UK Ltd trading as Taylor & Francis. This is an author-produced version of a paper subsequently published in Expert Review of Pharmacoeconomics and Outcomes Research. Uploaded in accordance with the publisher's self-archiving policy. |
Keywords: | Cancer; Combination therapy; Cost-effectiveness; Costs; Economic evaluation; Value-based pricing |
Dates: |
|
Institution: | The University of Sheffield |
Academic Units: | The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield) > ScHARR - Sheffield Centre for Health and Related Research |
Depositing User: | Symplectic Sheffield |
Date Deposited: | 29 Jan 2021 13:51 |
Last Modified: | 14 Feb 2022 15:37 |
Status: | Published |
Publisher: | Taylor & Francis |
Refereed: | Yes |
Identification Number: | 10.1080/14737167.2021.1879644 |
Related URLs: | |
Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:170602 |